vastcenters.blogg.se

Exact same PEEK interbody device – only now, truly differentiated in the spine market with a PEEKplus nanotexture.

While this FDA clearance is specific to Vallum, its nanotexturing technology can be inexpensively applied to any fully manufactured PEEK interbody device without altering its design or size, and without affecting mechanical or chemical properties. “I believe one of the most important of those technological advances is surface modification at the nano-scale, and Vallum’s FDA clearance is a significant step down that very promising path.” Edelman, MD, PhD, who provided the earliest advice and encouragement to Vallum’s management team.

“Technological advances to improve the performance of implantable medical devices are taking many forms,” said Prof. PEEKplus is not a coating, it is not porous, and no chemicals are infused into the PEEK. Importantly, nanotexturing below 100 nanometers has been shown to be beneficial to osteoblast functions that are necessary to grow bone and promote fusion. Nano-scale concavities of 20-50 nanometers are created by the impact of argon atoms across the entire existing microsurface of the PEEK to create the nanotexture of PEEKplus. Vallum’s PEEKplus nanotextured surface is unique in the spinal device market. PEEKplus is the first and only FDA-cleared nanotextured surface on a PEEK interbody device. Vallum Corporation, a medical device company, has received clearance from the US Food and Drug Administration (FDA) to market a polyetheretherketone (PEEK) spinal interbody fusion device with a PEEKplus nanotextured surface created by Vallum’s proprietary and patented Accelerated Neutral Atom Beam (ANAB) technology. Vallum's spinal interbody fusion device PEEKplus Nanotexturing receives US FDA approval You can get e-magazine links on WhatsApp.